ScholarIQanswers from OpenAlex

Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial

PaperCitations, authors & open-access status

Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial have?

ScholarIQcitation count

Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial has 199 citations in the OpenAlex counts ScholarIQ stores.

When was Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial published?

ScholarIQyear

Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial has 2004 year in the ScholarIQ index.

What is the open-access status of Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial?

ScholarIQoa status

Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial has closed oa status in the ScholarIQ index.

What is the DOI of Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial?

ScholarIQdoi

The DOI for Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial is on the source record.

What is the PMID of Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial?

ScholarIQpmid

The PMID for Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial is on the source record.

What is the OpenAlex record for Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial?

ScholarIQopenalex

The OpenAlex for Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial